AIIB and Gavi Partner to Unlock $1 Billion for Sustainable Health and Immunization Financing
The Asian Infrastructure Investment Bank (AIIB) and Gavi, the Vaccine Alliance, have entered into a landmark partnership aimed at bolstering sustainable health and immunization financing across low-income and lower middle-income countries.
The letter of intent, signed by AIIB President Jin Liqun and Gavi CEO Dr. Sania Nishtar in Geneva, outlines a joint commitment to mobilize up to USD 1 billion in financing to strengthen health systems in AIIB member states eligible for Gavi support.
Under this strategic collaboration, AIIB will support public sector health projects with concessional resources from Gavi. The goal: to enhance vaccine access, improve health infrastructure, and assist countries transitioning from Gavi support toward self-financing.
This includes investments in immunization delivery, procurement of high-impact vaccines, and health system resilience.
“Investing in human health is investing in our future,” said AIIB President Jin. “This partnership underscores our commitment to helping countries access life-saving vaccines, especially when urgency is key.”
Since its inception, Gavi has supported the immunization of over 1.1 billion children and helped prevent more than 18 million deaths. Its new partnership with AIIB aligns with its 25th anniversary vision of delivering greater impact through innovative financing, particularly as health systems face growing threats from infectious diseases and climate-related shocks.
Dr. Nishtar emphasized the importance of sustainable financing, stating, “We are excited to leverage our expertise to strengthen immunization programs and help countries build lasting health resilience through this innovative partnership.”
Beyond financing, the two institutions plan to explore additional tools such as blended finance and donor liquidity mechanisms, while fostering knowledge-sharing on climate-health intersections and sustainable health infrastructure.
